ComplianceFeaturesLegal FTC and FDA Issue Warnings to CBD Marketers May 1, 2019 By Ginny Pasqualone In a rare joint sanctions effort, regulators crack down on product claims, just as cannabidiol products take off.This content is restricted to site members. If you are an existing user, please log in. New users may register below.Existing Users Log InUsername or EmailPassword Remember Me New User RegistrationChoose a Username*First Name*Last Name*Address 1*Address 2City*State*Zip*Country*Day Phone*Email**Required field cannabidoilcbdFarm BillFDAFTCGinny PasqualoneKelly Dryeregulation 0 comment 0 Facebook Twitter Google + Pinterest previous post Do Non-Compete and Non-Solicitation Clauses Hold Up in Court? next post Getting Real with Modere’s CEO Asma Ishaq Related Articles Positive Outlook for Public Companies September 1, 2021 Direct Selling Critics, Old and New, Join Regulators... June 1, 2021 LOOK FOR OUR NOVEMBER DIGITAL ISSUE IN YOUR... November 1, 2022 New Round of FTC Warning Letters Sends Direct... July 1, 2020 Navigating AI’s New Era: FTC Focuses on Consumer... December 3, 2023 LOOK FOR OUR NOVEMBER ISSUE IN YOUR MAILBOX.... November 1, 2021 Class Action Award Penalizes ViSalus $925M for Illegal... August 1, 2019 LuLaRoe Settles DSA-Supported Lawsuit March 1, 2021 Public Company CEOs Share Quarterly Earnings July 3, 2019 Embracing Industry Self-Regulation January 1, 2021
